Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |